|
Balaxi Pharmaceuticals Ltd |
Trading |
|
|
BSE Code |
|
532597 |
|
|
|
ISIN Demat |
|
INE618N01014 |
|
|
|
Book Value |
|
117.0934413 |
|
|
|
Mar.Cap(Rs.Cr) |
|
656.92 |
|
|
|
P/E |
|
80.37 |
|
|
|
Face Value |
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
Years | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Debt-Equity Ratio | 0.10 | 0.05 | 0.05 | 0.00 | 0.00 | Long Term Debt-Equity Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | Current Ratio | 2.55 | 2.07 | 2.41 | 3.43 | 2.72 | Fixed Assets | 19.92 | 62.72 | 179.11 | 456.30 | 1360.00 | Inventory | 145.15 | 10129.00 | 204.40 | 109.95 | 0.00 | Debtors | 1.66 | 2.02 | 2.19 | 2.49 | 4.97 | Interest Cover Ratio | 45.02 | 198.00 | 138.27 | 184.80 | 0.00 | PBIDTM (%) | 21.71 | 19.79 | 23.98 | 20.25 | 17.94 | PBITM (%) | 21.23 | 19.55 | 23.87 | 20.23 | 17.94 | PBDTM (%) | 21.24 | 19.70 | 23.81 | 20.14 | 17.94 | CPM (%) | 15.48 | 14.73 | 17.52 | 14.27 | 14.49 | APATM (%) | 15.00 | 14.48 | 17.42 | 14.25 | 14.49 | ROCE (%) | 27.93 | 37.15 | 55.40 | 58.43 | 96.25 | RONW (%) | 21.62 | 29.00 | 42.40 | 41.10 | 77.71 |
|
|
|
|